摘要:
The invention relates to novel thiophene derivatives of the formula (I) ##STR1## in which X represents halogen, alkyl, alkoxy, alkylthio, halogenoalkyl, halogenoalkoxy, nitro or cyano, or two substituents X, together with the carbon atoms to which they are attached, form a saturated or unsaturated, optionally substituted ring, n represents a number from 1 to 3, and Z represents one of the groups ##STR2## in which A, B, D, G, have the meaning given in the description, to processes for their preparation and to their use as pesticides and herbicides.
摘要:
An alkylative cycloaddition method is provided that is particularly useful for the synthesis of many of the Vitamin D analogues with differing side chains. Thus, a preferred synthesis is of Vitamin D analogues having a side chain R.sub.1 where a substantially geometrically pure first precursor having the structure ##STR1## and a second precursor are provided, the second precursor being a 1,7 enyne. These precursors are reacted in the presence of a palladium catalyst to form compounds having the structure ##STR2## where R.sub.2 hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group, and R.sub.3 is hydrogen, hydroxyl, lower alkoxy, fluorine, or a protecting group.
摘要:
This invention relates to new aryl ureas and methods for their synthesis. The inventive compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.
摘要:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
摘要:
A compound of Formula (I): salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by raf, VEGFR, PDGFR, p38 and flt-3.
摘要:
This invention relates to methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes.
摘要:
In one aspect, the present invention relates to compounds of Formula (I): to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to method for their preparation.
摘要:
In one aspect, the present invention relates to compounds of Formula (I) and to pharmaceutically acceptable salts thereof, wherein: n is 1 to 4; and R3 in each occurrence is independently selected from —X—R5, —W—R6, —C(O)—N(R3a)—S(O)2—R3b, —C(R3a)═N—R3y, C(R3a)═N—N(R3a)—C(O)—R3b, C(R3a)═N—N(R3a)—C(O)2—R3b, —C(R3a)═N—N(R3y)2, —C(R3a)═N—N(R3a)—C(O)—N(R3y)2, —C(NR3a)2)═N—R3y, —C(N(R3a)2)═N—OR3y, —C(N(R3a)2)═N—C(O)—R3b, —C(N(R3a)2═N—S(0)2—R3b, —C(N(R3a)2)═N—CN, —N═C(R3y)2, —N(R3a)—S(O)2—N(R3y)2, —N(R3a)—N(R3y2, —N(R3a)—C(O)—N(R3y)2, —N(R3a)—C(O)—N(R3a)—S(O)2—R3b, —N(R3a)—C(R3a)═N(R3y), —N(R3a)—C(R3a)═N—OR3y, —N(R3a)—C(R3a)═N—C(O)—R3b, —N(R3a)—C(R3a)═N—S(O)2R—3b, —N(R3a)—C(R3a)═N—CN, —N(R3a)—C(N(R3a)2)═N—R3y, —N(R3a)—C(N(R3a)2)═N—OR3y, —N(R3a)—C(N(R3a)2)═N—C(O)—R3b, —N(R3a)—C(N(R3a)2)—N—S(O)2—R3b, —N(R3a)—C(N(R3a)2)—N—CN, —O—C(O)—R3, and —Si(R3b)3; to methods of using them to treat bacterial infections, and to methods for their preparation.
摘要:
This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.